Table 2.
Characteristics of patients with ventricular tachyarrhythmias (n = 10)
| n = 10 | |
|---|---|
| Male sex | 2 (20) |
| Age, y | 48 ± 16 (95% CI: 38–58) |
| Diagnosis | |
| NICM | 6 (60) |
| PPCM | 4 (40) |
| LVEF at diagnosis, % | 21.2 ± 6.1 (95% CI: 17.4‐25.0) |
| NYHA class at baseline | 2.9 ± 0.7 (95% CI: 2.5 ± 3.3) |
| Rhythm at baseline | |
| Sinus | 8 (80) |
| AF | 2 (20) |
| HR at baseline, bpm | 85 ± 20 (95% CI: 73–98) |
| QRS duration at diagnosis, ms | 116 ± 23 (95% CI: 102–130) |
| NT‐proBNP at diagnosis, ng/L | 6339 ± 6747 (95% CI: 2158–10 521) |
| Medications at discharge | |
| β‐Blocker | 10 (100) |
| ACEI/ARB | 10 (100) |
| MRA | 9 (90) |
| Diuretics | 8 (80) |
| Ivabradine | 3 (30) |
| Digitalis | 2 (20) |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; CI, confidence interval; HR, heart rhythm; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; NICM, nonischemic cardiomyopathy; NT‐proBNP, N‐terminal pro b‐type natriuretic peptide; NYHA, New York Heart Association; PPCM, peripartum cardiomyopathy; QRS, QRS interval; SD, standard deviation.
Data are presented as n (%) or mean ± SD.